We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s (including associated symptoms such as weight loss, diarrhea, cramps, frequent fevers and/or joint pain), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
